Health Condition 1: L814- Other melanin hyperpigmentation
Conditions
Interventions
Intervention1: Trannexamic Acid Mesotherapy: Mesotherapy will be done using MESO-ICE device and injectable Tranexamic acid (500mg) will be used as the medium for mesotherapy. Patients will be advised
Sponsors
Dr Yash Kashikar
Eligibility
Inclusion criteria
Inclusion criteria: A clinical diagnosis of melasma between the ages of 18 to 65 years
Exclusion criteria
Exclusion criteria: Patients suffering from significant systemic illness and on certain drugs such as anticoagulants, oral contraceptive pills, hormone replacement therapy, NSAIDs, antiepileptic medications, isotretinoin, or any other phototoxic medication, with known hypersensitivity to Tranexamic acid Pre-existing facial dermatoses Past history of thrombotic disease such as deep vein thrombosis Pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of Melasma Assesment & Severity Index score (MASI) by Tranexamic acid mesotherapy in comparison to topical applicationTimepoint: Baseline, 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of MASI score by Tranexamic acid mesotherapy in comparison to topical applicationTimepoint: 8 weeks | — |
Countries
India
Contacts
Public ContactDr Yash Kashikar
Datta Meghe Institute of Higher Education & Research Sawangi
Outcome results
None listed